- Home
- ASLE vs VNDA Comparison
ASLE vs VNDA Comparison
Compare ASLE & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASLE
- VNDA
- Stock Information
- Founded
- ASLE 2008
- VNDA 2002
- Country
- ASLE United States
- VNDA United States
- Employees
- ASLE N/A
- VNDA N/A
- Industry
- ASLE Industrial Specialties
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- ASLE Consumer Discretionary
- VNDA Health Care
- Exchange
- ASLE Nasdaq
- VNDA Nasdaq
- Market Cap
- ASLE 277.0M
- VNDA 275.2M
- IPO Year
- ASLE N/A
- VNDA 2006
- Fundamental
- Price
- ASLE $6.11
- VNDA $4.21
- Analyst Decision
- ASLE Buy
- VNDA Strong Buy
- Analyst Count
- ASLE 3
- VNDA 2
- Target Price
- ASLE $8.00
- VNDA $16.50
- AVG Volume (30 Days)
- ASLE 272.1K
- VNDA 565.2K
- Earning Date
- ASLE 08-06-2025
- VNDA 07-31-2025
- Dividend Yield
- ASLE N/A
- VNDA N/A
- EPS Growth
- ASLE N/A
- VNDA N/A
- EPS
- ASLE N/A
- VNDA N/A
- Revenue
- ASLE $320,302,000.00
- VNDA $203,467,000.00
- Revenue This Year
- ASLE $2.54
- VNDA $16.86
- Revenue Next Year
- ASLE $16.24
- VNDA $39.78
- P/E Ratio
- ASLE N/A
- VNDA N/A
- Revenue Growth
- ASLE N/A
- VNDA 11.78
- 52 Week Low
- ASLE $4.53
- VNDA $3.81
- 52 Week High
- ASLE $8.76
- VNDA $5.55
- Technical
- Relative Strength Index (RSI)
- ASLE 51.86
- VNDA 34.31
- Support Level
- ASLE $5.77
- VNDA $4.15
- Resistance Level
- ASLE $6.21
- VNDA $4.89
- Average True Range (ATR)
- ASLE 0.21
- VNDA 0.16
- MACD
- ASLE 0.00
- VNDA -0.08
- Stochastic Oscillator
- ASLE 47.80
- VNDA 7.50
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.